Atlas Trials

Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)

Clinical trial NCT00002036 · COMPLETED

Trial details

NCT number
NCT00002036
Sponsor
Abbott
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.